About Oberland Capital
Oberland Capital is a private equity firm founded in 2013. It is primarily based in New York City, United States. In the last 12 months, it has participated in 1 funding round.
Overall Oberland Capital portfolio has seen 12 IPOs and 3 acquisitions, namely Invitae, Verastem and BillionToOne. A lot of funds co-invest with Oberland Capital, with names like Polaris Partners sharing a substantial percentage of its portfolio.
Oberland Capital has a team of 16 people, including 8 partners.
Key Metrics
Oberland Capital's Portfolio
They have invested in a total of 18 companies. Their most recent investment was in Primmune Therapeutics (Series B round) on Jan 26, 2026. Here is the most recent investment by Oberland Capital:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Jan 26, 2026 | Series B | 1285 | ||
May 19, 2025 | Post IPO | 3057 | - | |
Apr 28, 2025 | Post IPO | 1444 | - | |
Jan 11, 2024 | Post IPO | 4219 | - |
Here is the portfolio snapshot of Oberland Capital:
Investments by Year
The maximum number of investments were made in 2023
Team profile of Oberland Capital
Oberland Capital has a team of 16 members including 8 Partners and 4 Principals located in United States. Oberland Capital's team does not sit on the board of any company as of now.Here is a list of top team members in Oberland Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | New York City | - | ||
Partner | New York City | - | ||
Partner | New York City | - | ||
Partner | New York City | - | ||
Partner | Boca Raton | - | ||
Partner | New York City | - | ||
Partner | New York City | - | - | |
Principal | New York City | - | - | |
Principal | New York City | - | ||
Principal | New York City | - |
Co-investors of Oberland Capital
Over the past 13 years, 3 investors have co-invested in Oberland Capital's portfolio companies.
- Top Co-investors of Oberland Capital: 3 investors entered a company along with Oberland Capital. These include investors like Polaris Partners (1 company).
Oberland Capital News
•
MeiraGTx Announces $400 Million Strategic Investment by Oberland CapitalGlobeNewswire•Jul 07, 2026•MeiraGTx, Oberland Capital
•
•
Oberland Capital’s Investment in ClearPoint NeuroGlobal Legal Chronicle•May 19, 2025•Oberland Capital, ClearPoint Neuro, Covington & Burling, Sheppard Mullin
•
•
Biohaven to receive investment of up to $600M by Oberland CapitalSeeking Alpha•Apr 28, 2025•Biohaven, Oberland Capital
•
•
Verastem secures funding & partnership to launch ovarian cancer drug in mid-2025.Bakersfield•Jan 13, 2025•Verastem, Oberland Capital, IQVIA
•
Verastem Oncology announces debt refinancing with Oberland CapitalSeeking Alpha•Jan 13, 2025•Verastem, Oberland Capital
•
BillionToOne secures $140M financing agreement with Oberland CapitalLabPulse.com•Sep 05, 2024•BillionToOne, Oberland Capital
•
Oberland Capital’s $320 Million Investment in ImmunityBioGlobal Legal Chronicle•Jan 11, 2024•Oberland Capital, ImmunityBio, Wilson Sonsini Goodrich & Rosati